A prospective study of fasting plasma glucose and risk of stroke in asymptomatic men

Mayo Clinic Proceedings

Volumn 86, Issue 11, 2011, Pages 1042-1049

  Sui, Xuemei ^a   Lavie, Carl J ^b   Hooker, Steven P ^a   Lee, Duck Chul ^a   Colabianchi, Natalie ^a   Lee, Chong Do ^c   Blair, Steven N ^a  

^a UNIVERSITY OF SOUTH CAROLINA   (United States)

^b UNIVERSITY OF QUEENSLAND   (Australia)

^c ARIZONA STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE;

ADULT; AGE; AGED; ARTICLE; CONTROLLED STUDY; DIABETES MELLITUS; GLUCOSE BLOOD LEVEL; HUMAN; HYPERGLYCEMIA; MAJOR CLINICAL STUDY; MALE; MORTALITY; OUTCOMES RESEARCH; PROSPECTIVE STUDY; REGISTER; RISK ASSESSMENT; STROKE;

EID: 80055078579     PISSN: 00256196     EISSN: None     Source Type: Journal    
DOI: 10.4065/mcp.2011.0267     Document Type: Article

References (39)

1. Stamler J, Vaccaro O, Neaton JD, Wentworth D. Diabetes, other risk factors, and 12-yr cardiovascular mortality for men screened in the Multiple Risk Factor Intervention Trial. Diabetes Care. 1993;16(2):434-444. (Pubitemid 23046633)
2. Tuomilehto J, Rastenyte D. Diabetes and glucose intolerance as risk factors for stroke. J Cardiovasc Risk. 1999;6(4):241-249. (Pubitemid 29421886)
3. Tuomilehto J, Rastenyte D, Jousilahti P, Sarti C, Vartiainen E. Diabetes mellitus as a risk factor for death from stroke: prospective study of the middle-aged Finnish population. Stroke. 1996;27(2):210-215. (Pubitemid 26044488)
4. Howard BV, Rodriguez BL, Bennett PH, et al. Prevention Conference VI: diabetes and cardiovascular disease; Writing Group I: epidemiology. Circulation. 2002;105(18):e132-e137.
5. Goldstein LB, Adams R, Becker K, et al. Primary prevention of ischemic stroke: a statement for healthcare professionals from the Stroke Council of the American Heart Association. Circulation. 2001;103(1):163-182. (Pubitemid 32050453)
6. Lenzen M, Ryden L, Ohrvik J, et al. Diabetes known or newly detected, but not impaired glucose regulation, has a negative influence on 1-year outcome in patients with coronary artery disease: a report from the Euro Heart Survey on Diabetes and the Heart. Eur Heart J. 2006;27(24):2969-2974. (Pubitemid 44950440)
7. Haffner SM, Lehto S, Ronnemaa T, Pyorala K, Laakso M. Mortality from coronary heart disease in subjects with type 2 diabetes and in nondiabetic subjects with and without prior myocardial infarction. N Engl J Med. 1998;339(4):229-234. (Pubitemid 28350165)
8. Ryden L, Standl E, Bartnik M, et al. Guidelines on diabetes, pre-diabetes, and cardiovascular diseases: executive summary: the Task Force on Diabetes and Cardiovascular Diseases of the European Society of Cardiology (ESC) and of the European Association for the Study of Diabetes (EASD). Eur Heart J. 2007;28(1):88-136. (Pubitemid 46137814)
9. Tanne D, Koren-Morag N, Goldbourt U. Fasting plasma glucose and risk of incident ischemic stroke or transient ischemic attacks: a prospective cohort study. Stroke. 2004;35(10):2351-2355. (Pubitemid 39311262)
10. Hyvarinen M, Tuomilehto J, Mahonen M, et al. Hyperglycemia and incidence of ischemic and hemorrhagic stroke-comparison between fasting and 2-hour glucose criteria. Stroke. 2009;40(5):1633-1637.
11. Hyvarinen M, Qiao Q, Tuomilehto J, et al. Hyperglycemia and stroke mortality: comparison between fasting and 2-h glucose criteria. Diabetes Care. 2009;32(2):348-354.
12. DECODE Study Group: the Eurpean Diabetes Epidemiology Group. Glucose tolerance and cardiovascular mortality: comparison of fasting and 2-hour diagnostic criteria. Arch Intern Med. 2001;161(3):397-405.
13. Preiss D, Welsh P, Murray HM, et al. Fasting plasma glucose in nondiabetic participants and the risk for incident cardiovascular events, diabetes, and mortality: results from WOSCOPS 15-year follow-up. Eur Heart J. 2010;31(10):1230-1236.
14. Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Report of the expert committee on the diagnosis and classification of diabetes mellitus. Diabetes Care. 2003;26(suppl 1):S5-S20.
15. Tai ES, Goh SY, Lee JJ, et al. Lowering the criterion for impaired fasting glucose: impact on disease prevalence and associated risk of diabetes and ischemic heart disease. Diabetes Care. 2004;27(7):1728-1734. (Pubitemid 38857451)
16. Davidson MB, Landsman PB, Alexander CM. Lowering the criterion for impaired fasting glucose will not provide clinical benefit. Diabetes Care. 2003;26(12):3329-3330. (Pubitemid 37466896)
17. Borch-Johnsen K, Colagiuri S, Balkau B, et al. Creating a pandemic of prediabetes: the proposed new diagnostic criteria for impaired fasting glycaemia. Diabetologia. 2004;47(8):1396-1402. (Pubitemid 39232425)
18. Schriger DL, Lorber B. Lowering the cut point for impaired fasting glucose: where is the evidence? Where is the logic? Diabetes Care. 2004;27(2):592-601.
19. Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Report of the expert committee on the diagnosis and classification of diabetes mellitus. Diabetes Care. 1997;20(7):1183-1197.
20. Lyerly GW, Sui X, Lavie CJ, Church TS, Hand GA, Blair SN. The association between cardiorespiratory fitness and risk of all-cause mortality among women with impaired fasting glucose or undiagnosed diabetes mellitus. Mayo Clin Proc. 2009;84(9):780-786.
21. Hooker SP, Sui X, Colabianchi N, et al. Cardiorespiratory fitness as a predictor of fatal and nonfatal stroke in asymptomatic women and men. Stroke. 2008;39(11):2950-2957.
22. Shuger SL, Sui X, Church TS, Meriwether RA, Blair SN. Body mass index as a predictor of hypertension incidence among initially healthy normotensive women. Am J Hypertens. 2008;21(6):613-619. (Pubitemid 351733374)
23. Balke B, Ware RW. An experimental study of physical fitness in Air Force personnel. U S Armed Forces Med J. 1959;10:675-688.
24. Gibbons LW, Mitchell TL, Wei M, Blair SN, Cooper KH. Maximal exercise test as a predictor of risk for mortality from coronary heart disease in asymptomatic men. Am J Cardiol. 2000;86(1):53-58. (Pubitemid 30365143)
25. Sesso HD, Gaziano JM, Glynn RJ, Buring JE. Value of an endpoints committee versus the use of nosologists for validating cause of death. Contemp Clin Trials. 2006;27(4):333-339. (Pubitemid 43928878)
26. Anderson RN, Miniño AM, Hoyert DL, Rosenberg HM. Comparability of cause of death between ICD-9 and ICD-10: preliminary estimates. Natl Vital Stat Rep. 2001;49(2):1-32.
27. Kelly-Hayes M, Robertson JT, Broderick JP, et al. The American Heart Association stroke outcome classification. Stroke. 1998;29(6):1274-1280. (Pubitemid 28265492)
28. Blair SN, Goodyear NN, Gibbons LW, Cooper KH. Physical fitness and incidence of hypertension in healthy normotensive men and women. JAMA. 1984;252(4):487-490. (Pubitemid 14088099)
29. Sui X, LaMonte MJ, Blair SN. Cardiorespiratory fitness as a predictor of nonfatal cardiovascular events in asymptomatic women and men. Am J Epidemiol. 2007;165(12):1413-1423. (Pubitemid 47240791)
30. Hu FB, Stampfer MJ, Colditz GA, et al. Physical activity and risk of stroke in women. JAMA. 2000;283(22):2961-2967. (Pubitemid 30414508)
31. Barlow CE, Lamonte MJ, Fitzgerald SJ, Kampert JB, Perrin JL, Blair SN. Cardiorespiratory fitness is an independent predictor of hypertension incidence among initially normotensive healthy women. Am J Epidemiol. 2006;163(2):142-150. (Pubitemid 43068983)
32. Adams HP Jr, Putman SF, Kassell NF, Torner JC. Prevalence of diabetes mellitus among patients with subarachnoid hemorrhage. Arch Neurol. 1984;41(10):1033-1035. (Pubitemid 14041741)
33. Barzilay JI, Spiekerman CF, Wahl PW, et al. Cardiovascular disease in older adults with glucose disorders: comparison of American Diabetes Association criteria for diabetes mellitus with WHO criteria. Lancet. 1999;354(9179):622- 625. (Pubitemid 29391425)
34. Wagenknecht LE, D'Agostino R Jr, Savage PJ, O'Leary DH, Saad MF, Haffner SM. Duration of diabetes and carotid wall thickness: the Insulin Resistance Atherosclerosis Study (IRAS). Stroke. 1997;28(5):999-1005. (Pubitemid 27209149)
35. Chiquette E, Chilton R. Cardiovascular disease: much more aggressive in patients with type 2 diabetes. Curr Atheroscler Rep. 2002;4(2):134-142.
36. Mudaliar S. Intense management of diabetes mellitus: role of glu-cose control and antiplatelet agents. J Clin Pharmacol. 2004;44(4):414-422. (Pubitemid 38392016)
37. Gilmore RM, Stead LG. The role of hyperglycemia in acute ischemic stroke. Neurocrit Care. 2006;5(2):153-158. (Pubitemid 44729641)
38. Blair SN, Kannel WB, Kohl HW, Goodyear N, Wilson PWF. Surrogate measures of physical activity and physical fitness: Evidence for sedentary traits of resting tachycardia, obesity, and low vital capacity. Am J Epidemiol. 1989;129(6):1145-1156. (Pubitemid 19148457)
39. Xu JQ, Kochanek KD, Murphy SL, Tejada-Vera B. Deaths: final data for 2007. Natl Vital Stat Rep. 2010;58(19):1-136. http://www.cdc.gov/nchs/data/nvsr/ nvsr58/nvsr58-19.pdf. Accessed July 1. 2011.